Year-end Sale % OFF 
Abstract
BackgroundAnxiety and cardiac autonomic modulations (CAM) were thoroughly investigated in coronary artery disease (CAD) and cardiac syndrome X (CSX) patients worldwide, but not among Sudanese with similar pathology.AimsTo compare levels of anxiety and CAM between Sudanese patients with CSX and CAD.Materials and MethodsAnxiety was evaluated in 51 CAD and 26 CSX patients using Taylor Manifest anxiety score (TMAS) questionnaire while heart rate variability derived indices were used to assess CAM, namely natural logarithm of low frequency (LnLF), high frequency (LnHF) and LF/HF ratio (LnLF/HF).ResultsLow anxiety levels were achieved by 6 (23.1%) and 9 (17.6%) patients with CSX and CAD respectively. High anxiety level was achieved by only one (3.8%) patient, who was suffering from CSX. TMAS was significantly higher in CSX (31.27 (21.97)) compared to CAD (21.86 (12.97), P = 0.021). However, abnormally increased anxiety was not associated with higher risk of CSX. LnLF, LnHF and LnLF/HF were comparable in CAD and CSX patients.ConclusionCSX and CAD patients showed comparable CAM. Although anxiety levels were higher in CSX compared to CAD, TMAS ≥ 35 failed to show significant association with CSX.
Highlights
Presence of typical angina and significant risk factors of atherosclerosis usually points to coronary artery disease (CAD) [1]
Anxiety was evaluated in 51 CAD and 26 cardiac syndrome X (CSX) patients using Taylor Manifest anxiety score (TMAS) questionnaire while heart rate variability derived indices were used to assess cardiac autonomic modulations (CAM), namely natural logarithm of low frequency (LnLF), high frequency (LnHF) and LF/HF ratio (LnLF/HF)
Anxiety levels were higher in CSX compared to CAD, TMAS ! 35 failed to show significant association with CSX
Summary
To compare levels of anxiety and CAM between Sudanese patients with CSX and CAD. OPEN ACCESS Citation: Lutfi MF (2017) Anxiety Level and Cardiac Autonomic Modulations in Coronary Artery Disease and Cardiac Syndrome X Patients.
Sign-in/Register to view highlights & summary 
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
